Oncopeptides AB Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 3, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	64	24	57	91	52	1,028
Market Cap Growth	189.48%	-57.28%	-37.99%	76.61%	-94.98%	80.91%
Enterprise Value	64	15	47	58	-3	917
Last Close Price	0.24	0.11	0.40	0.65	0.46	10.17
PS Ratio	12.88	10.58	20.58	137.15	5.35	-
PB Ratio	123.08	6.17	12.76	3.89	3.00	19.99
P/TBV Ratio	123.08	6.17	12.76	3.89	3.02	20.05
EV/Sales Ratio	12.52	6.38	17.01	86.70	-	-
Debt / Equity Ratio	22.75	2.61	2.31	0.02	0.07	0.03
Asset Turnover	0.24	0.13	0.11	0.02	0.17	-
Inventory Turnover	0.21	0.78	-	-	-	-
Quick Ratio	3.27	3.74	4.26	4.22	1.78	2.44
Current Ratio	3.42	4.23	4.52	4.25	1.83	2.53
Return on Equity (ROE)	-376.73%	-512.51%	-141.91%	-133.80%	-363.13%	-232.14%
Return on Assets (ROA)	-57.86%	-73.20%	-50.66%	-52.59%	-134.59%	-97.95%
Return on Capital Employed (ROCE)	-158.10%	-146.50%	-130.70%	-115.80%	-697.10%	-256.70%
Earnings Yield	-33.28%	-85.00%	-34.38%	-29.49%	-226.15%	-13.83%
FCF Yield	-28.37%	-77.93%	-38.59%	-36.92%	-239.82%	-11.39%
Buyback Yield / Dilution	-58.45%	-84.14%	-9.80%	-9.33%	-20.72%	-20.63%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.